FDA approves twice-yearly HIV shot. What to know
The Food and Drug Administration has approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections. The drug will be marketed under the name Yeztugo and sell for an annual …